Amphastar Pharmaceuticals AMPH
NASDAQ AMPH
$26.68 -0.71 (-2.59%)
At close: Sep 29, 2026 · 4:00 PM EDT

Amphastar Pharmaceuticals (AMPH) Revenue (2013 - 2026)

Updated

Amphastar Pharmaceuticals (AMPH) reported Revenue of $183.9 million for Q2 2026, up 5.4% from $174.41 million a year earlier and up 7.4% from the prior quarter.

Analysis

Amphastar Pharmaceuticals (AMPH) Revenue (2013 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Amphastar Pharmaceuticals' Revenue came in at $730.02 million, up 1.0% year-over-year; for FY2025, it came in at $719.89 million, down 1.7% from FY2024.

  • Revenue has a five-year compound annual growth rate of 15.5% (FY2020 to FY2025).
  • By year, Revenue came in at $731.97 million in FY2024 (+13.6%), $644.4 million in FY2023 (+29.1%), $498.99 million in FY2022 (+14.0%) and $437.77 million in FY2021 (+25.1%).
  • Five-year quarterly Revenue spans a low of $112.2 million in Q3 2021 and a high of $191.84 million in Q3 2025.
  • Year over year, Revenue gained in five of the last eight quarters, with growth averaging 1.2%.
  • The high point for year-over-year Revenue in five years was Q3 2023 (growth of 50.3%); the low point was Q2 2025 (a decline of 4.4%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $171.17 million (Q1 2026), $183.11 million (Q4 2025) and $191.84 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 25.31 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 16.99 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.38 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 7.80 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.33 Bn
10 Amphastar Pharmaceuticals 1.16 Bn 23.86 Mn 93.47 Mn 183.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 183.90 Mn
Mar 31, 2026 171.17 Mn
Dec 31, 2025 183.11 Mn
Sep 30, 2025 191.84 Mn
Jun 30, 2025 174.41 Mn
Mar 31, 2025 170.53 Mn
Dec 31, 2024 186.52 Mn
Sep 30, 2024 191.21 Mn
Jun 30, 2024 182.39 Mn
Mar 31, 2024 171.84 Mn
Dec 31, 2023 178.11 Mn
Sep 30, 2023 180.56 Mn
Jun 30, 2023 145.71 Mn
Mar 31, 2023 140.02 Mn
Dec 31, 2022 135.02 Mn
Sep 30, 2022 120.13 Mn
Jun 30, 2022 123.47 Mn
Mar 31, 2022 120.37 Mn
Dec 31, 2021 120.89 Mn
Sep 30, 2021 112.20 Mn
API Access

Amphastar Pharmaceuticals Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=AMPH&period=max&api_key=YOUR_API_KEY